Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carlsson

Showing results (521-530 of 600) with videos related to

Pageof 60
Sort By:
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk CohortLena L Law, Kate E Sprecher, Ryan J Dougherty, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2020
Amyloid duration is associated with preclinical cognitive decline and tau PETRebecca L Koscik, Tobey J Betthauser, Erin M Jonaitis, et al.
Brain Imaging and Behavior|June 11, 2017
Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adultsAnnie M Racine, Andrew P Merluzzi, Nagesh Adluru, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 10, 2015
Occupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's DiseaseElizabeth A Boots, Stephanie A Schultz, Rodrigo P Almeida, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Older more fit KL-VS heterozygotes have more favorable AD-relevant biomarker profilesMackenzie Jarchow, Ira Driscoll, Brianne M Breidenbach, et al.
Brain : a Journal of Neurology|December 31, 2019
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-ageTobey J Betthauser, Rebecca L Koscik, Erin M Jonaitis, et al.
Sleep Advances : a Journal of the Sleep Research Society|October 18, 2021
Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration StudiesAdam P Spira, Vadim Zipunnikov, Rema Raman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEmma F Bublitz, Carol A Van Hulle, Hannah Zylstra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumEmma F Bublitz, Carol A Van Hulle, Hannah Zylstra, et al.
Clinical Chemistry|March 2, 2024
CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic ChallengesErin M Jonaitis, Beckie Jeffers, Monica VandenLangenberg, et al.
Pageof 60

Showing results (521-530 of 600) with videos related to

Sort By:
Pageof 60
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk CohortLena L Law, Kate E Sprecher, Ryan J Dougherty, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2020
Amyloid duration is associated with preclinical cognitive decline and tau PETRebecca L Koscik, Tobey J Betthauser, Erin M Jonaitis, et al.
Brain Imaging and Behavior|June 11, 2017
Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adultsAnnie M Racine, Andrew P Merluzzi, Nagesh Adluru, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 10, 2015
Occupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's DiseaseElizabeth A Boots, Stephanie A Schultz, Rodrigo P Almeida, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Older more fit KL-VS heterozygotes have more favorable AD-relevant biomarker profilesMackenzie Jarchow, Ira Driscoll, Brianne M Breidenbach, et al.
Brain : a Journal of Neurology|December 31, 2019
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-ageTobey J Betthauser, Rebecca L Koscik, Erin M Jonaitis, et al.
Sleep Advances : a Journal of the Sleep Research Society|October 18, 2021
Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration StudiesAdam P Spira, Vadim Zipunnikov, Rema Raman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEmma F Bublitz, Carol A Van Hulle, Hannah Zylstra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumEmma F Bublitz, Carol A Van Hulle, Hannah Zylstra, et al.
Clinical Chemistry|March 2, 2024
CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic ChallengesErin M Jonaitis, Beckie Jeffers, Monica VandenLangenberg, et al.
Pageof 60